Health Care/Hospital

Minesto presents today at Naventus Renewables Summit, Stockholm

GOTHENBURG, Sweden, March 26, 2024 /PRNewswire/ -- Minesto's CEO Dr Martin Edlund presents today at Naventus Renewables Summit held in Stockholm, 26 March 2024.   The event is livestreamed, and Minesto will be presenting at 14.40 CET:   Naventus & Partners Renewables Summit 2024 For additional ...

2024-03-26 17:56 688

Cicada Innovations launches HealthTech Hub in Western Sydney's "hidden innovation ecosystem"

SYDNEY, March 26, 2024 /PRNewswire/ -- Australia's flagship deep tech incubator  Cicada Innovations is officially opening the doors to the "Cicada HealthTech Hub " on 25 March 2024, officiated...

2024-03-26 10:00 873

Alphamab Oncology Announces the First Patient Dosed in Australia in the Clinical Study of Subcutaneous Formulation JSKN033

SUZHOU, China, March 26, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been dosed inAustralia in the clinical study (JSKN033-101) of JSKN033, a subcutaneous formulation with HER2 bispecific antibody-conjugated drug and PD-L1 monoclonal antibody,...

2024-03-26 09:57 911

Scivita Medical Expands Collaboration with Boston Scientific

SUZHOU, China, March 26, 2024 /PRNewswire/ -- Recently, Scivita Medical Technology Co., Ltd. ("Scivita Medical") and Boston Scientific Corporation (NYSE: BSX), a leading global medical technology company, joined hands again to sign an expanded strategic cooperation arrangement.

2024-03-26 09:30 1008

BioDuro-Sundia's Partner, DigmBio Announced IND Clearance from Korea MFDS for its Selective PARP1 Inhibitor DM5167

SHANGHAI, March 26, 2024 /PRNewswire/ -- BioDuro-Sundia's partner, DigmBio, a South Korean biotechnology company, announced its selective PARP1 inhibitor for the treatment of triple-negative breast cancer has been approved by Korea Food and Drug Administration (MFDS) for Investigational New Drug ...

2024-03-26 08:30 904

Full-Life Technologies Achieves Regulatory Milestone with Nuclear Permit, Advancing Radioisotope Facility Construction

GEMBLOUX, Belgium, March 25, 2024 /PRNewswire/ -- Full-Life Technologies ("Full-Life"), today announced the recent achievement of its subsidiary "Full-Life Technology Europe" has obtained a Nuclear Permit for a class IIA facility from the Belgium Federal Agency for Nuclear Control ("FANC"), auth...

2024-03-26 08:00 656

Smart Home Fitness Brand SupeRun and Online Competition Platform PitPat Unite for Easter Million-Dollar Challenge

HOUSTON, March 25, 2024 /PRNewswire/ -- If you own any SupeRun smart treadmill, download the PitPat App and sign up for the Easter Challenge on it. The race begins onMarch 31st at 8:30 PM PST. The champion team wins and shares the $5000 cash prize! The two brands plan to launch a series of relate...

2024-03-25 23:00 1026

Yunkang Announces 2023 Annual Results, Revenue Reaches RMB892 Million

Steps up R&D investment Focuses on precision medicine and intelligent testing sectors HONG KONG, March 25, 2024 /PRNewswire/ -- Yunkang Group Limited ("Yunkang" or the "Group"; Stock Code: 2325), a leading medical operation services provider in China, has announced its annual results for the year...

2024-03-25 22:54 1424

GenieMD Awarded Frost & Sullivan's 2024 Company of the Year Award for Pioneering Virtual Chronic Disease Management Solutions Through Its Unified Virtual Care Platform

GenieMD offers a comprehensive virtual care platform, integrating telehealth, remote patient monitoring, chronic care management, and AI-driven insights to impact the treatment and management of chronic diseases. SAN ANTONIO, March 25, 2024 /PRNewswire/ -- Frost & Sullivan recently researched th...

2024-03-25 22:31 1153

LILYSILK and NBCF Partner to Launch Caring Collection, Elevating Breast Cancer Support and Awareness

NEW YORK, March 25, 2024 /PRNewswire/ -- LILYSILK , the world's leading silk brand with a mission to inspire people to live spectacular, sustainable lives, is proud to announce the continuation and strengthe...

2024-03-25 22:00 904

WuXi XDC Delivers Outstanding Performance in 2023 with over 110% Year-On-Year Growth for Both Revenue and Adjusted Net Profit and Achieves Significant Corporate Milestones

* Revenue reached RMB 2,124 million, an increase of 114% compared with Year 2022 * Adjusted net profit reached RMB 412 million, an increase of 112% compared with Year 2022 * Total number of integrated projects increased to 143 * 50 new integrated projects signed in 2023 * Number of Phase...

2024-03-25 21:39 1701

GC Genome to Present New Data at AACR 2024

Offering Hope for Enhanced Early Detection and Patient Care in the Battle Against Cancer YONGIN, South Korea, March 25, 2024 /PRNewswire/ -- GC Genome Corporation, a leading diagnostics company, today announced that the company will present two poster presentations at the American Association fo...

2024-03-25 21:00 1134

Sirtex Medical Appoints Matt Schmidt as New Chief Executive Officer and Board of Directors Member

WOBURN, Mass., March 25, 2024 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of interventional treatment solutions, announced today the appointment ofMatt Schmidt as chief executive officer and board of directors member, effectiveMarch 25. Since joining Sirtex in 2023, Schmidt...

2024-03-25 20:00 1113

CGTN: China advances battle against tuberculosis

BEIJING, March 25, 2024 /PRNewswire/ -- World Tuberculosis (TB) Day, which falls onMarch 24 every year, is designed to build public awareness that TB today remains a global public health problem that seriously endangers people's health. According to the World Health Organization's (WHO) Global T...

2024-03-25 15:12 1246

ANNOUNCEMENT OF 2023 ANNUAL RESULTS OF TONG REN TANG TECHNOLOGIES

BEIJING, March 25, 2024 /PRNewswire/ -- Tong Ren Tang Technologies Co. Ltd. (" Tong Ren Tang Technologies" or the "Group", 1666.HK) is pleased to announce the audited consolidated results of the Group for the year ended31 December 2023. In 2023, the Group's revenue amounted to RMB6.77 billion, rep...

2024-03-25 12:47 1699

Medipledge, a premium post-laser skincare brand, just launched in Australia

SYDNEY, March 25, 2024 /PRNewswire/ -- On March 24th, 2024, Medipledge, a premium skincare brand developed by experts in beauty and dermatology, successfully launched inAustralia.   The launch event, held in Australia, featured high-tech elements and included high-end aesthetic therapists, lead...

2024-03-25 10:09 777

New PeerLINC Knowledge Hub will Leverage Local Expertise and Experience to Accelerate New, More Effective TB Cures Around the World

Hub will focus on supporting global use of new treatments that effectively treated drug-resistant TB in 98% of Filipino participants MANILA, Australia, March 25, 2024 /PRNewswire/ -- TB Alliance's new Peer-to-Peer Learning for Innovative Cures (PeerLINC) Knowledge Hub launched today inManila, wi...

2024-03-25 10:00 634

Australian Government Grants TB Alliance an Award to Help Bolster Clinical Research and Improve Access to New Treatments for Drug-Resistant TB

AUD 17 Million Grant over 5 Years Will Fund Next-Generation TB Cures CANBERRA, Australia, March 25, 2024 /PRNewswire/ -- The Australian Government, through the Partnerships for a Healthy Region initiative, has announced a new AUD 17 million grant to support work with TB Alliance through its Pro...

2024-03-25 08:04 568

Veeva Vault EDC Surpasses 1,000 Study Start Milestone

Eight of the top 20 biopharmas standardize on Vault EDC to build a modern clinical data foundation SINGAPORE, March 25, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Veeva Vault EDC powered more tha...

2024-03-25 08:00 1112
123456 ... 802

Week's Top Stories